Posaconazole Prophylaxis for CAPA Prevention in Critically-Ill Patients

NCT05065658 · clinicaltrials.gov ↗

COMPLETED

Status

249

Enrollment

OTHER

Sponsor class

Conditions

COVID-19 Respiratory Infection
Aspergillosis

Interventions

DRUG: Posaconazole

Sponsor

Medical University of Graz

Collaborators

[object Object]